The Emory University School of Medicine is ranked among the nation's finest institutions for patient care, education, and biomedical research. The Emory University Department of Medicine, led by program director Lorenzo Di Francesco, MD, FACP, supports several different options for residency training including:
- There are approximately 50 positions per year in this category.
American Board of Internal Medicine (ABIM) Research Pathway – Two-year program
- There are approximately three positions per year in this category.
Medicine/Psychiatry – Five-year program
- There are approximately two positions per year in this category.
Preliminary track – One-year program
- Thirty (30) one-year positions – Preliminary* and Transitional**
Over the course of their residency training program, residents participate in a broad-based educational curriculum that emphasizes achieving complete competence in general internal medicine, as well as allowing for balanced experiences in all the internal medicine subspecialties.
We utilize an integrated educational program that includes core didactics delivered at each of the Emory University affiliated hospitals with a group of strategically placed layered programs that reinforce the achievement of the key clinical skills in internal medicine. In addition, we provide high level training curricula that focus on leadership, teaching, communication, evidence based medicine, procedural competence, performance improvement and transitions of care.
*The Preliminary one-year positions are primarily reserved for applicants matching in Emory's Radiation Oncology orNeurology residency programs.
**The Transitional one-year positions are primarily reserved for applicants who are matching for advanced training in Emory residencies including Anesthesiology, Radiology, Neurology, Ophthalmology and Dermatology.
In The News
Feb 18 Emory University to offer free online Ebola course
Feb 18 Measles: Frequently Asked Questions
Feb 12 Emory's Critical Care NP/PA Residency Program accredited by ANCC
Feb 8 Mining immune systems of Ebola survivors for therapeutic gold